Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ribeiro Rodrigues, Rodrigo ^a   Kim, Soyeon ^b   Coelho Da Silva, Flávia Dias ^a   Uzelac, Aleksandra ^b   Collins, Lauren ^c   Palaci, Moíses ^a   Alland, David ^b   Dietze, Reynaldo ^a   Ellner, Jerrold J ^c   Jones López, Edward ^c   Salgame, Padmini ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; ADOLESCENT; AGED; MIDDLE AGED; PROCEDURES; STANDARDS; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84901259401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096564     Document Type: Article

References (56)

1. WHO (2012) Global Tuberculosis Report 2012.
2. Prasad TS, Verma R, Kumar S, Nirujogi RS, Sathe GJ, et al. (2013) Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis. Clin Proteomics 10: 8.
3. Trajman A, Steffen RE, Menzies D (2013) Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med 2013: 601737.
4. Munoz L, Santin M (2013) Interferon-gamma release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review. J Infect 66: 381-387.
5. Mulder C, Mulleners B, Borgdorff MW, van Leth F (2013) Predictive value of the tuberculin skin test among newly arriving immigrants. PLoS One 8: e60130.
6. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F (2005) Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 40: 211-217. (Pubitemid 40110663)
7. Pineiro R, Mellado MJ, Cilleruelo MJ, Garcia-Ascaso M, Medina-Claros A, et al. (2012) Tuberculin skin test in bacille Calmette-Guerin-vaccinated children: how should we interpret the results? Eur J Pediatr 171: 1625-1632.
8. Mahan CS, Johnson DF, Curley C, van der Kuyp F (2011) Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guerin vaccinated persons. Int J Tuberc Lung Dis 15: 174-178, i.
9. Lee YM, Park KH, Kim SM, Park SJ, Lee SO, et al. (2013) Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection.
10. Moran-Mendoza O, Tello-Zavala MC, Rivera-Camarillo M, Rios-Meza Y (2013) Comparison of different methods and times for reading the tuberculin skin test. Int J Tuberc Lung Dis 17: 1273-1278.
11. Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204. (Pubitemid 44713473)
12. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527.
13. Lalvani A, Pareek M (2010) Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 28: 245-252.
14. Morrison J, Pai M, Hopewell PC (2008) Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 8: 359-368.
15. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, et al. (2009) T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13: 84-92.
16. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, et al. (2013) Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187: 206-211.
17. Mantegani P, Piana F, Codecasa L, Galli L, Scarpellini P, et al. (2006) Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection. Clin Med Res 4: 266-272. (Pubitemid 46166378)
18. Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, et al. (2007) Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 7: 122.
19. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, et al. (2009) Analysis of discordance between the tuberculin skin test and the interferongamma release assay. Int J Tuberc Lung Dis 13: 446-453.
20. Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
21. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
22. WHO (2013) Global tuberculosis report.
23. (2002) Controle Da Tuberculose. Uma Proposata de Integraçao Ensino-Serviço 5a ediçao Ministerio Da Saúde Rio de Janeiro
24. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77.
25. Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215.
26. Lighter J, Rigaud M, Huie M, Peng CH, Pollack H (2009) Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 13: 731-736.
27. Whittaker E, Gordon A, Kampmann B (2008) Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One 3: e3901.
28. Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, et al. (2008) Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 3: e2858.
29. Yassin MA, Petrucci R, Garie KT, Harper G, Teshome A, et al. (2013) Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection. Eur Respir J 41: 644-648.
30. Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15-21.
31. Diel R, Loddenkemper R, Nienhaus A (2012) Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 142: 63-75.
32. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354. (Pubitemid 351650594)
33. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, et al. (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosisburden country. JAMA 293: 2756-2761. (Pubitemid 40965087)
34. Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, et al. (2009) Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 33: 1374-1382.
35. Barnes PF (2004) Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 170: 5-6.
36. Lalvani A, Richeldi L, Kunst H (2005) Interferon gamma assays for tuberculosis. The Lancet Infectious Diseases 5: 322-324.
37. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174: 349-355. (Pubitemid 44156616)
38. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49-55.
39. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, et al. (2007) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175: 618-627. (Pubitemid 46438947)
40. Mardani M, Tabarsi P, Mohammadtaheri Z, Chitsaz E, Farokhzad B, et al. (2010) Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. Ann Thorac Med 5: 43-46.
41. Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, et al. (2011) Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis (Edinb) 91: 322-326.
42. Anibarro L, Trigo M, Villaverde C, Pena A, Gonzalez-Fernandez A (2011) Tuberculin skin test and interferon-gamma release assay show better correlation after the tuberculin 'window period' in tuberculosis contacts. Scand J Infect Dis 43: 424-429.
43. Dheda K, van Zyl Smit R, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
44. Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, et al. (2012) Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 185: 427-434.
45. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N (2013) Challenges with QuantiFERON-TB Gold Assay for Large-Scale, Routine Screening of US Healthcare Workers. Am J Respir Crit Care Med.
46. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, et al. (2009) Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 16: 1170-1175.
47. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlosser S, et al. (2011) Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol 18: 1176-1182.
48. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, et al. (2012) Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 67: 62-70.
49. Tuuminen T (2013) It Is High Time To Reevaluate QuantiFERON-TB Gold for Clinical Practice. Clin Vaccine Immunol 20: 1778.
50. Chegou NN, Detjen AK, Thiart L, Walters E, Mandalakas AM, et al. (2013) Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One 8: e64226.
51. Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, et al. (2011) A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 91: 260-267.
52. Bass JB, Sanders RV, Kirkpatrick MB (1985) Choosing an appropriate cutting point for conversion in annual tuberculin skin testing. Am Rev Respir Dis 132: 379-381. (Pubitemid 15229398)
53. (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49: 1-51.
54. Mancuso JD, Bernardo J, Mazurek GH (2013) The elusive "gold" standard for detecting Mycobacterium tuberculosis infection. Am J Respir Crit Care Med 187: 122-124.
55. Denkinger CM, Dheda K, Pai M (2011) Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17: 806-814.
56. Fox GJ, Barry SE, Britton WJ, Marks GB (2013) Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 41: 140-156.